OP-1690
OP-1690 is a complete estrogen receptor (ERα) antagonist (CERAN), with pIC50 values of 7.5 and 7.9 in alkaline phosphatase (AP) activity assay and TR-FRET assay, respectively. OP-1690 modulates receptor function by inducing ERα tetramerization, effectively induces ERα degradation, inhibits target gene transcription, but exhibits low antiproliferative potency. OP-1690 can be used for breast cancer research.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Formel: C31H35ClF2N2O2
- Molecular Weight:541.07
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
- Protokoll
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
Biologische Aktivität
Beschreibung
IC50 & Target
[1]|
ERα 7.5 (pIC50) |
In Vitro
OP-1690 (7 d) inhibits the proliferation of MCF7 and CAMA-1 cells with pIC50 values of 6 and 5.9, respectively, which are lower than those of Fulvestrant (HY-13636) and RAD1901 (HY-19822).
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Parmacokinetics
Chemical Information
-
Molecular Weight 541.07
-
Formel C31H35ClF2N2O2
-
SMILES
FC1=CC=CC=C1C2(CCCC2)CN(CC3=CC=CC(O)=C3Cl)C4=CC=C(OC5CN(CCCF)C5)C=C4
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
OP-1690 Related Classifications
HY-181345 Related Classifications
Powered by Bioz